Chevy Chase Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q4 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 229,767 shares of REGN stock, worth $146 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
229,767
Previous 238,379
3.61%
Holding current value
$146 Million
Previous $251 Million
34.69%
% of portfolio
0.51%
Previous 0.78%
Shares
31 transactions
Others Institutions Holding REGN
# of Institutions
1,494Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.92 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.38 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.5 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.08 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.02 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $68.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...